纵横研报
Industry

检测与认证服务

05Reports
·检测与认证服务 ·In-house Research

ALS Limited: A High-Quality Compounder with a Cyclical Sidecar

ALS Limited is a global laboratory-testing group that earns most of its revenue from Life Sciences yet a disproportionate share of margin from minerals-related Commodities testing, so a diversified TIC provider still trades, at key moments, like a high-quality miner's service proxy. FY26 delivered record revenue of A$3.32 billion and an 18.0% underlying EBIT margin, hitting the FY27 strategic targets a year early, but at A$23.36 the stock trades near 37 times trailing EPS with the margin of safety put at zero. Rating Hold: a strong dual-engine testing franchise whose price already discounts commodities strength, acquisition repair and future hub productivity, leaving little room for disappointment.

Hold
·检测与认证服务 ·In-house Research

SGS: High-Quality TIC Compounder at Full Value

SGS SA is the world's broadest publicly listed testing, inspection and certification group, monetizing accreditation, network density and a century-old reputation for independence across more than 2,500 facilities in 115 countries. In 2025 it generated CHF 6.945 billion of sales at a 16.0% adjusted operating margin and converted profit to cash at roughly 1.9x net income, yet at about 25.9x trailing earnings and a 3.6% dividend yield the market already prices the Strategy 27 reacceleration, leaving no conservative margin of safety against a CHF 80-84 fair value. Rating Hold: a high-quality TIC compounder whose current price captures most of the Strategy 27 improvement and leaves limited conservative upside.

Hold
ITRK.LSE logo
·检测与认证服务 ·In-house Research

Intertek: Quality Compounder on a Takeover Bid

Intertek Group is a global ATIC (assurance, testing, inspection, certification) provider that sells trust as much as lab work, running a five-division Total Quality Assurance portfolio across consumer products, supply chains, food, infrastructure and energy. In 2025 it grew revenue 4.3% at constant currency to GBP 3.43 billion and lifted its adjusted operating margin 90 basis points to 18.1%, yet at around GBP 57 the shares now trade chiefly on EQT's GBP 60.0 indicative cash proposal rather than on operating momentum, leaving little standalone margin of safety against a roughly 35-40% downside if the bid lapses. Rating Hold: a proven quality compounder whose current price already capitalizes most of the margin-improvement and strategic-optionality story, leaving thin reward for fresh capital.

Hold
·检测与认证服务 ·In-house Research

Bureau Veritas: Quality TIC, Priced for Reacceleration

Bureau Veritas is an 1828-founded global testing, inspection and certification network operating across six lines that sells institutional trust, with 2025 revenue of EUR 6.47 billion, a 16.3% adjusted operating margin, and EUR 824 million of free cash flow. The real question is durability rather than quality: after a strong 2024 of 10.2% organic growth, Q1 2026 organic growth slowed to 4.5% and management trimmed full-year guidance on Government Services contract exits, leaving the stock at about 18.4x 2025 adjusted EPS of EUR 1.42 with a conservative fair value near EUR 23 already below the current EUR 26.16 price. Rating Hold: Bureau Veritas remains a strong TIC franchise, but the current price already discounts much of the LEAP 28 plan before 2026 re-acceleration is proven.

Hold
·检测与认证服务 ·内部研究

欧陆科学 (Eurofins Scientific SE, ERF.PA) 横纵研报

欧陆科学是 1987 年 Gilles Martin 在法国南特创办、卢森堡注册总部、全球最大的检测与认证服务(TIC)龙头,业务覆盖食品 / 环境 / 制药 / 临床诊断 / 消费品五大领域、雇员约 6.4 万、900 多家实验室遍布 50+ 国家;FY2025 营收 EUR 7.30 B(同比 +5.0% 报告 / +4.1% 有机)、调整后 EBITDA 利润率 22.5%(成熟业务 24.3%)、每股收益 EUR 2.31(+24%);Martin 家族通过 Analytical Bioventures 持股 32.9% 经济权益 / 65.8% 投票权;2024-06 Muddy Waters 发布做空报告指控自我交易后、虽公司全面驳回但市场治理折扣未完全消化。

观察